After two miscarriages, couple Talia and Dan worried whether a child was in their future. The third time they became pregnant, they were excited and also nervous. They wanted a way to know whether their child would be healthy. They tried noninvasive prenatal testing (NIPT) - a screening test from Illumina. The test screens for multiple fetal chromosomal aneuploidies using a single maternal blood draw. Now with a healthy baby boy, the couple reflects on the value of NIPT and its ability to provide them with peace of mind throughout their pregnancy. Learn more about the latest advances in reproductive and genetic health solutions from Illumina. [link to RGH page http://www.illumina.com/clinical/reproductive-genetic-health.ilmn]